Anti-Rabies Serum Market Outlook 2026–2035: Growth Drivers and Industry Forecast
Uncover key drivers, emerging technologies, and competitive movements shaping the anti-rabies serum market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Anti-Rabies Serum Market be in 2030 compared with 2026?
The market for anti-rabies serum has experienced robust expansion in recent times. Projections indicate a rise from $1.5 billion in 2025 to $1.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.6%. Historically, this growth has been driven by factors such as a rise in rabies exposure incidents, broader adoption of emergency treatment protocols in hospitals, the availability of immunoglobulins derived from equines, governmental initiatives for rabies control, and enhanced understanding of post-exposure prophylaxis.
The anti-rabies serum market is projected to experience robust expansion in the coming years. This market is set to reach $1.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period is driven by factors such as the greater uptake of human anti-rabies immunoglobulin, broadened rabies prevention efforts in emerging economies, increased funding in biologics production, an escalating emphasis on safer serum options, and reinforced public health vaccination systems. Key trends anticipated during this period encompass a rise in the use of human-derived immunoglobulins, a growing preference for prefilled syringe designs, an extended distribution network optimized for cold-chain requirements, a heightened focus on high-purity antibody compositions, and enhanced standardization of post-exposure prophylaxis guidelines.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp
What Drivers Are Guiding Growth Patterns In The Anti-Rabies Serum Market?
The anticipated increase in the incidence of dog bites is projected to fuel the expansion of the anti-rabies serum market going forward. Dog bites are injuries resulting from a dog biting or scratching an individual, ranging in severity from minor to severe, and can lead to infections, significant wounds, and potentially transmit diseases like rabies. Prompt medical intervention and effective prevention are essential for managing and mitigating the risks associated with these bites. Several elements contribute to the growing prevalence of dog bites, including greater urbanization causing more frequent human-dog interactions, a higher presence of unrestrained or poorly trained dogs, and inadequate public awareness regarding dog behavior and bite avoidance. This uptick in dog bite cases has consequently boosted the demand for anti-rabies serum, given its critical role in preventing rabies in individuals potentially exposed to infected animals through timely application. For instance, in 2023, according to the American Veterinary Medical Association, a US-based non-profit organization, the average cost for dog bite insurance claims in 2023 was $58,545. Insurers disbursed $1.12B for liability claims associated with dog bites and various dog-related injuries in 2023, with such claims witnessing an increase of nearly 10% that year. Thus, the rising occurrence of dog bites is a significant factor driving the growth of the anti-rabies serum market.
How Is The Anti-Rabies Serum Market Divided Into Segments?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
Which Market Trends Are Opening Growth Opportunities In The Anti-Rabies Serum Market?
Leading companies in the anti-rabies serum market are forming strategic alliances to bolster product advancement and widen market access. These strategic partnerships involve a process where businesses combine their strengths and resources to achieve mutual gains and success. As an illustration, in July 2023, Kedrion S.p.A., a US-based biopharmaceutical company, collaborated with Kamada, an Israel-based biopharmaceutical company, to distribute KEDRAB (Rabies Immune Globulin [Human]) within the US. This joint venture has been vital for the co-development and licensing of the product in the U.S., alongside promoting greater disease awareness. Through their collective endeavors, the partnership has played a role in protecting individuals exposed to bites from rabid animals from serious and potentially life-threatening conditions.
Which Key Market Players Are Investing In Expansion And Innovation Within The Anti-Rabies Serum Market?
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report
Which Regions Are Poised For Strategic Growth In The Anti-Rabies Serum Market?
North America was the largest region in the anti-rabies serum market in 2025. The regions covered in the anti-rabies serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Anti-Rabies Serum Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20468&type=smp
Browse Through More Reports Similar to the Global Anti-Rabies Serum Market 2026, By The Business Research Company
Rabies Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report
Animal Therapeutics And Diagnostics Market Report 2026
Anti Inflammatory Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
